ELIZABETH LICHTSINN: Open Payments
NPI 1235780362 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$825 in 38 payments from 10 companies in 2025. Trend: 2023 $766 · 2024 $869 · 2025 $825
Food & beverage: $825
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $187 |
| Galderma Laboratories, L.P. | 2 | $153 |
| Regeneron Healthcare Solutions, Inc. | 4 | $131 |
| LEO Pharma Inc. | 4 | $99 |
| UCB, Inc. | 3 | $74 |
| Incyte Corporation | 2 | $59 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $46 |
| Amgen Inc. | 2 | $41 |
| Lilly USA, LLC | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: NEMLUVIO, DUPIXENT, SKYRIZI, RINVOQ, Bimzelx, OPZELURA, ANZUPGO, ILUMYA.
Industry payments across IN — which companies pay providers there.
